B. Braun Medical to Close Interventional Systems Division

October 9, 2026—B. Braun announced that it will wind down and close the B. Braun Interventional System Inc. (BIS) division. B. Braun stated that the action is part of the company's continued efforts to streamline operations and focus resources on strategic priorities and core businesses.

According to B. Braun, the BIS portfolio includes medical devices for interventional radiology, pediatric and congenital interventional cardiology, vascular surgery, and pulmonology. The devices are used for angioplasty and valvuloplasty, congenital and structural heart, percutaneous drainage, vena cava filters, vascular access and interventional accessories.

BIS expects to continue commercial sales through March 31, 2027. There is no immediate disruption to product supply. B. Braun further stated that during the transition, BIS will continue supporting its customers and will work with suppliers to develop an orderly transition to new distributors where appropriate.

B. Braun advised that BIS will communicate directly with customers and suppliers as transition plans are finalized. Customers should continue using their existing BIS sales and customer service contacts for questions regarding products, availability and open orders, stated the company.